Metraipolis › archive › dc_cf3ef534b82a

Evolution of the prostate cancer diagnostic paradigm: integrated evidence and clinical pathways from targeted biopsy to biopsy-free strategy — Europe PMC PMID:42421680

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42421680
DOI
10.3389/fonc.2026.1835580
License (as archived)
solo-consultazione
Archived
2026-10-19T04:19:15.440Z
SHA-256 of the archived text
258b16361f60e96c2cd4d5aae09e214c12c52f7cd4045be46a98b4b7a0588e79
Stable URL of this page
https://metraipolis.com/documento/dc_cf3ef534b82a

How to cite

Evolution of the prostate cancer diagnostic paradigm: integrated evidence and clinical pathways from targeted biopsy to biopsy-free strategy — Europe PMC PMID:42421680 — Europe PMC (en), https://europepmc.org/article/MED/42421680 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cf3ef534b82a (Metraipolis archive dc_cf3ef534b82a, sha256 258b16361f60e96c2cd4d5aae09e214c12c52f7cd4045be46a98b4b7a0588e79)
BibTeX
@misc{dccf3ef534b82a,
  title = {Evolution of the prostate cancer diagnostic paradigm: integrated evidence and clinical pathways from targeted biopsy to biopsy-free strategy — Europe PMC PMID:42421680},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42421680},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cf3ef534b82a; sha256 258b16361f60e96c2cd4d5aae09e214c12c52f7cd4045be46a98b4b7a0588e79},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42421680. Agents can read the archived copy with the MCP tool read_document.